Van Cleef Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.9M | Buy |
7,570
+116
| +2% | +$25K | 0.19% | 49 |
|
|
2026
Q1 | $1.62M | Sell |
7,454
-50
| -0.7% | -$11.1K | 0.17% | 48 |
|
|
2025
Q4 | $1.71M | Buy |
7,504
+29
| +0.4% | +$6.61K | 0.17% | 48 |
|
|
2025
Q3 | $1.73M | Hold |
7,475
| – | – | 0.18% | 48 |
|
|
2025
Q2 | $1.39M | Sell |
7,475
-230
| -3% | -$42.7K | 0.15% | 51 |
|
|
2025
Q1 | $1.61M | Hold |
7,705
| – | – | 0.18% | 48 |
|
|
2024
Q4 | $1.37M | Hold |
7,705
| – | – | 0.15% | 55 |
|
|
2024
Q3 | $1.52M | Hold |
7,705
| – | – | 0.17% | 53 |
|
|
2024
Q2 | $1.32M | Hold |
7,705
| – | – | 0.17% | 52 |
|
|
2024
Q1 | $1.4M | Sell |
7,705
-50
| -0.6% | -$8.62K | 0.18% | 53 |
|
|
2023
Q4 | $1.2M | Buy |
7,755
+100
| +1% | +$14.6K | 0.17% | 55 |
|
|
2023
Q3 | $1.14M | Sell |
7,655
-25
| -0.3% | -$3.67K | 0.18% | 53 |
|
|
2023
Q2 | $1.03M | Sell |
7,680
-1,600
| -17% | -$235K | 0.16% | 54 |
|
|
2023
Q1 | $1.48M | Sell |
9,280
-40
| -0.4% | -$6.12K | 0.23% | 51 |
|
|
2022
Q4 | $1.51M | Buy |
9,320
+200
| +2% | +$30.7K | 0.25% | 49 |
|
|
2022
Q3 | $1.22M | Sell |
9,120
-310
| -3% | -$44.5K | 0.24% | 51 |
|
|
2022
Q2 | $1.44M | Hold |
9,430
| – | – | 0.24% | 49 |
|
|
2022
Q1 | $1.53M | Hold |
9,430
| – | – | 0.22% | 50 |
|
|
2021
Q4 | $1.28M | Sell |
9,430
-260
| -3% | -$30.7K | 0.18% | 52 |
|
|
2021
Q3 | $1.04M | Sell |
9,690
-75
| -0.8% | -$8.57K | 0.16% | 58 |
|
|
2021
Q2 | $1.1M | Sell |
9,765
-150
| -2% | -$16.9K | 0.16% | 58 |
|
|
2021
Q1 | $1.07M | Sell |
9,915
-200
| -2% | -$21.4K | 0.17% | 59 |
|
|
2020
Q4 | $1.08M | Sell |
10,115
-100
| -1% | -$9.61K | 0.18% | 54 |
|
|
2020
Q3 | $895K | Sell |
10,215
-1,050
| -9% | -$98.9K | 0.17% | 57 |
|
|
2020
Q2 | $1.11M | Buy |
11,265
+900
| +9% | +$79.2K | 0.23% | 53 |
|
|
2020
Q1 | $790K | Sell |
10,365
-1,960
| -16% | -$167K | 0.19% | 59 |
|
|
2019
Q4 | $1.09M | Sell |
12,325
-200
| -2% | -$16.6K | 0.22% | 58 |
|
|
2019
Q3 | $948K | Sell |
12,525
-52
| -0.4% | -$3.56K | 0.21% | 57 |
|
|
2019
Q2 | $915K | Buy |
12,577
+501
| +4% | +$39.4K | 0.2% | 60 |
|
|
2019
Q1 | $973K | Buy |
12,076
+360
| +3% | +$29.5K | 0.23% | 57 |
|
|
2018
Q4 | $1.08M | Buy |
11,716
+296
| +3% | +$26K | 0.29% | 48 |
|
|
2018
Q3 | $1.08M | Sell |
11,420
-615
| -5% | -$58.3K | 0.24% | 47 |
|
|
2018
Q2 | $1.11M | Buy |
12,035
+160
| +1% | +$15.6K | 0.27% | 47 |
|
|
2018
Q1 | $1.12M | Sell |
11,875
-115
| -1% | -$12.6K | 0.28% | 48 |
|
|
2017
Q4 | $1.16M | Sell |
11,990
-125
| -1% | -$11.8K | 0.29% | 51 |
|
|
2017
Q3 | $1.08M | Hold |
12,115
| – | – | 0.29% | 48 |
|
|
2017
Q2 | $878K | Hold |
12,115
| – | – | 0.26% | 55 |
|
|
2017
Q1 | $789K | Sell |
12,115
-78
| -0.6% | -$4.9K | 0.24% | 59 |
|
|
2016
Q4 | $764K | Hold |
12,193
| – | – | 0.24% | 59 |
|
|
2016
Q3 | $769K | Hold |
12,193
| – | – | 0.26% | 56 |
|
|
2016
Q2 | $755K | Sell |
12,193
-25
| -0.2% | -$1.52K | 0.26% | 56 |
|
|
2016
Q1 | $698K | Sell |
12,218
-425
| -3% | -$23.7K | 0.25% | 57 |
|
|
2015
Q4 | $749K | Sell |
12,643
-250
| -2% | -$14.4K | 0.27% | 58 |
|
|
2015
Q3 | $702K | Sell |
12,893
-22
| -0.2% | -$1.43K | 0.28% | 58 |
|
|
2015
Q2 | $868K | Hold |
12,915
| – | – | 0.32% | 52 |
|
|
2015
Q1 | $756K | Sell |
12,915
-150
| -1% | -$9.06K | 0.28% | 55 |
|
|
2014
Q4 | $855K | Buy |
13,065
+1,105
| +9% | +$69.7K | 0.32% | 52 |
|
|
2014
Q3 | $691K | Buy |
11,960
+800
| +7% | +$44.4K | 0.28% | 50 |
|
|
2014
Q2 | $630K | Buy |
11,160
+2,000
| +22% | +$105K | 0.26% | 55 |
|
|
2014
Q1 | $471K | Buy |
9,160
+200
| +2% | +$10.1K | 0.21% | 61 |
|
|
2013
Q4 | $473K | Sell |
8,960
-200
| -2% | -$9.83K | 0.21% | 61 |
|
|
2013
Q3 | $410K | Hold |
9,160
| – | – | 0.2% | 63 |
|
|
2013
Q2 | $379K | Buy |
+9,160
| New | +$401K | 0.2% | 66 |
|
Other funds holding ABBV
Van Cleef Asset Management's ABBV Position: Q2 2026 in Review
Van Cleef Asset Management increased its AbbVie (ABBV) stake by 1.6% in Q2 2026, buying an estimated $25K and bringing the position to 7,570 shares worth $1.9M. The position accounts for 0.19% of the portfolio, ranked #49.
Van Cleef Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Van Cleef Asset Management held 7,570 shares of AbbVie worth $1.9M as of Q2 2026.
- Van Cleef Asset Management bought 116 AbbVie shares in Q2 2026, an estimated $25K.
- AbbVie made up 0.19% of Van Cleef Asset Management's portfolio in Q2 2026, its #49 holding.
- Van Cleef Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Van Cleef Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.